TMCI IPOs 6.95M* shares @$17.00—with concurrent secondary offering of 5.99M* shares at same price: https://www.globenewswire.com/news-release/2021/04/23/2215689/0/en/UPDATE-Treace-Medical-Concepts-Announces-Pricing-of-Upsized-Initial-Public-Offering.html Treace Medical Concepts, Inc. [is] a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions)… *Assuming exercise of underwriter’s option.